Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2009
10/20/2009US7605316 Plants and seeds of hybrid corn variety CH820648
10/20/2009US7605313 Plants and seeds of corn variety CV590239
10/20/2009US7605312 Plants and seeds of corn variety CV971868
10/20/2009US7605311 Plants and seeds of hybrid corn variety CH407425
10/20/2009US7605310 Inbred corn line BC5
10/20/2009US7605304 Obtained from mutagenic strains of Bacillus thuringiensis encoding endotoxins
10/20/2009US7605303 cloning a rice stress-responsive gene, RSI, using the isolated gene to breed NaCl and drought resistance plant but not resistance to abscisic acid; genetic engineering
10/20/2009US7605253 field of combination oligomers, including the block synthesis of combination oligomers in the absence of a template, as well as related methods, kits, libraries and other compositions.
10/20/2009US7605248 Recombinant constructs of Borrelia burgdorferi
10/20/2009US7605247 Nucleic acid molecules encoding a wheat sucrose transporter
10/20/2009US7605246 Genes differentially expressed in breast cancer
10/20/2009US7605245 PUFA polyketide synthase systems and uses thereof
10/20/2009US7605236 Immunoglobulins; lupus, rheumatoid arthritis, multiple sclerosis, myasthenia gravis, Hashimoto's disease, immunodeficiency syndrome, asthma, allergic disorders, AIDS, and proliferative disorders such as leukemia
10/20/2009US7605233 Tumour necrosis factor binding ligands
10/20/2009US7605232 Hydrogels for protein concentration
10/20/2009US7605231 Having organic compound as graft chain and high-molecular weight micelle containing the gelatin derivative; as organic compound, a low molecular weight compound such as succinic acid, ethylenediamine, or high-molecular weight compound such as polyethylene glycol can be used; adhesion preventing membrane
10/20/2009US7605229 Chimera; FC fragments; antibody overexpression; immunoglobulins; gene therapy
10/20/2009US7605228 Insecticidal toxin complex fusion proteins
10/20/2009US7605226 Meltrins
10/20/2009US7605142 used to treat tumor (osteosarcoma or Ewing's sarcoma); restenosis
10/20/2009US7605140 Endothelial growth factors; antiischemic agents; neovascularization
10/20/2009US7605133 Isolated peptides to treat alpha-synuclein diseases
10/20/2009US7605129 Splice variant of human placental growth hormone
10/20/2009US7605127 Truncated hepatocyte growth factor variant protein HGF/NK2
10/20/2009US7605122 sublingual formulations for promoting weight loss in a human on low caloric diet ,comprising reconstituted hCG, having a pH in the range of about 7.0 to 8.0, sodium carbonate buffer, an absorption-enhancing compound (corn oil, mineral oil), and a taste-enhancing agent (glycerin)
10/20/2009US7605003 Using apolipoprotein A1 (Apo A1), a truncated form of transthyretin, ("transthyretin Delta N10) and/or a cleavage fragment of inter- alpha -trypsin inhibitor heavy chain H4 (IAIH4 fragment) as diagnostic/prognostic indicators of cell proliferative disorders of urogenital systems
10/20/2009US7605000 Invention provides a DNA molecule capable of expressing a heterologous polypeptide under cold shock conditions, where the DNA molecule is preferably a self-replicating expression vector
10/20/2009US7604989 Prevention or delaying apoptosis in recombinant cell; obtainceks transforme with nucleotide sequences coding antiapoptotic agents, express sequences, monitor adjustment in apotosis activity
10/20/2009US7604982 High-throughput screening method for intergrin antagonist and new peptide screened therefrom
10/20/2009US7604972 Nicotianamine synthase
10/20/2009US7604970 Variants of the PapM polypeptide of bacteria of the Streptomyces genus
10/20/2009US7604961 VP1 of foot-and-mouth disease virus
10/20/2009US7604959 Cell-based assays employing voltage and calcium dyes
10/20/2009US7604944 Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same
10/20/2009US7604931 Cripto mutant and uses thereof
10/20/2009US7604824 Sovent extraction of hemagglutinin specific for acetyl-D-galactosamine residues of O-glycosidically linked oligosaccharide of glycophorin A by homogenizing seeds with a homogenizing agent comprising phosphate-buffered saline and glycine;centrifuging and filtering to collect supernatant; antitumor agent
10/20/2009US7604811 Inducing an immune response in mammals comprising administering an antigenic synthetic peptide containing Colonization FactorAntigen/I pilus protein T-cell epitopes encapsulated within a biodegradable matrix of glycolic acid-lactic acid copolymer; amino acid sequences; intestinal bioavailability
10/20/2009US7604810 Conserved Neisserial antigens
10/20/2009US7604808 Circovirus sequences associated with piglet weight loss disease (PWD)
10/20/2009CA2359667C Method of identifying n-terminal probnp
10/20/2009CA2341354C Dengue viruses that are replication defective in mosquitos for use as vaccines
10/20/2009CA2330183C Novel insulin analogs with enhanced zinc binding
10/20/2009CA2250085C Modulators of tnf receptor associated factor (traf), their preparation and use
10/20/2009CA2227467C Helper virus-free herpesvirus vector packaging system
10/15/2009WO2009126896A2 Methods and compositions for root knot nematode control
10/15/2009WO2009126725A1 Method of modulating neovascularization
10/15/2009WO2009126719A2 Commensal bacteria as signal mediators within a mammalian host
10/15/2009WO2009126688A2 Novel compositions and methods for the treatment of immune related diseases
10/15/2009WO2009126648A1 Zona pellucida binding peptides, expression vectors, compositions, and methods for species-specific immunocontraception of animals
10/15/2009WO2009126292A2 Biologically active peptidomimetic macrocycles
10/15/2009WO2009126208A2 Heat resistant plants and plant tissues and methods and materials for making and using same
10/15/2009WO2009126031A1 Recombinant protein enriched in a heparin binding site and/or a heparan sulfate binding site
10/15/2009WO2009125925A2 Growth factor-mimicking peptides and uses thereof
10/15/2009WO2009125826A1 Gene capable of being expressed specifically in endosperm of plant, promoter for the gene, and use of the gene and the promoter
10/15/2009WO2009125646A1 Tdp-43-storing cell model
10/15/2009WO2009125607A1 Apoptosis inducer
10/15/2009WO2009125424A2 Peptidomimetics with glucagon antagonistic and glp-1 agonistic activities
10/15/2009WO2009124948A1 Opiorphin peptide derivatives as potent inhibitors of enkephalin - degrading ectopetidases
10/15/2009WO2009124932A1 Peptides for inhibiting the hpv-e6 oncoprotein
10/15/2009WO2009124670A1 Methods involving ms4a12 and agents targeting ms4a12 for therapy, diagnosis and testing
10/15/2009WO2009124503A1 Use of protein extract from plant seed embryo and composition thereof
10/15/2009WO2009124362A1 Suppressor of the endogenous interferon- gamma
10/15/2009WO2009124353A1 Modified cpn10 and prr signalling
10/15/2009WO2009124333A1 Modified chaperonin 10 and prr signaling
10/15/2009WO2009104188A3 Photoactive nanostructure and method of manufacturing same
10/15/2009WO2009094636A3 Ixodes scapularis salivary proteins and methods of use for modulation of the alternative complement pathway
10/15/2009WO2009092113A3 Methods and compositions for the delivery of vaccines to disrupted epithelium
10/15/2009WO2009083958A8 Isolated polypeptides, polynucleotides useful for modifying water user efficiency, fertilizer use efficiency, biotic/abiotic stress tolerance, yield and biomass in plants
10/15/2009WO2009081136A3 Screening
10/15/2009WO2009077755A3 Latency associated protein construct with aggrecanase sensitive cleavage site
10/15/2009WO2009077744A3 Vaccines for brucellosis
10/15/2009WO2009074271A8 Peptides modulators of tubulin polymerisation
10/15/2009WO2009071914A3 Mutant proteins and methods for producing them
10/15/2009WO2009044158A3 Inhibitors and uses
10/15/2009WO2008151078A9 Methods and compositions for modulating bmp-10 activity
10/15/2009US20090260109 Methods of increasing abiotic stress tolerance and/or biomass in plants genterated thereby
10/15/2009US20090260107 Coleopteran-Resistant Transgenic Plants and Methods of Their Production
10/15/2009US20090260101 Heat resistant plants and plant tissues and methods and materials for making and using same
10/15/2009US20090260095 Gene Marker for Evaluating Genetic Ability for Carcass Weight in Bovine and Method for Evaluating Genetic Ability for Carcass Weight Using the Same
10/15/2009US20090260091 Using mutation in gene associated with monocyte chemoattractant protein-1detect, diagnose, prevent and treat vision disorders; Ccr2-deficient mice; drug screening
10/15/2009US20090259028 Prevention of leaching of ligands from affinity-based purification systems
10/15/2009US20090259025 Lactoferrin
10/15/2009US20090259024 recombination; sensors
10/15/2009US20090259023 Liquid buffered gdf-5 formulations
10/15/2009US20090259022 Cdna encoding the human alpha2 delta4 calcium channel subunit
10/15/2009US20090259021 Liquid Phase Peptide Synthesis of KL-4 Pulmonary Surfactant
10/15/2009US20090259019 Masp-2, a complement fixing enzyme, and uses for it
10/15/2009US20090258834 Plasma protein-binding ligands
10/15/2009US20090258832 Cytokines and Cytokine Receptors With Reduced Immunocencity
10/15/2009US20090258827 Transcription Factor Modulator
10/15/2009US20090258826 Pituitary adenylate cyclase activating peptide (PACAP) receptor (VPAC2) agonists and their pharmacological methods of use
10/15/2009US20090258825 HOPM1 Mediated disease resistance to Pseudomonas syringae in Arabidopsis
10/15/2009US20090258819 Reagents and Methods for Smooth Muscle Therapies
10/15/2009US20090258818 Compositions For the Treatment of Diabetes
10/15/2009US20090258426 Preferred segments of neural thread protein and method of using the same
10/15/2009US20090258424 Cellular Delivery of siRNA
10/15/2009US20090258420 Altered polypeptides, immunoconjugates thereof, and methods related thereto
10/15/2009US20090258409 Purified sr-p70 protein
10/15/2009US20090258400 Mutant Tyrosine Repressor, a Gene Encoding the Same, and a Method for Producing L-Dopa
10/15/2009US20090258396 Crustaceans as production systems for therapeutic proteins